Source: FinanzNachrichten

Novus Scientific: Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

UPPSALA, Sweden, April 24, 2019 /PRNewswire/ -- Researchers of the Erasmus University Medical Center in Rotterdam - the Netherlands, consider that the synthetic and fully resorbable TIGR Matrix su...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas Engstrom's photo - CEO of Novus Scientific

CEO

Thomas Engstrom

CEO Approval Rating

65/100

Read more